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Supplementary Figure 1. ABHD11 loss leads to HIF-1⍺ accumulation and inhibition of 2-OG 
dependent dioxygenases in aerobic conditions. 
 
(a) Schematic of HRE-GFPODD reporter. (b-d) HeLa HRE-GFPODD cells respond to oxygen and 
metabolic inhibition. In 21% oxygen (O2), GFP reporter levels are low (black line). Reporter 
 3 
cells incubated for 24 hours in 1% O2 (b) or following treatment with 1 mM DMOG (c), or 4 
mM dimethyl 2-OG (DM-2OG) (d) accumulate GFP. n=10,000 cells per sample (b-d). (e, f) 
ABHD11 depletion leads to HIF-1a accumulation in cells incubated in 21% oxygen. HeLa HRE-
GFPODD cells (e) or HeLa wildtype cells (f) expressing Cas9 were lentivirally transduced with up 
to 3 sgRNA targeting ABHD11 and HIF-1a levels measured by immunoblot. b-actin served as 
a loading control. (g) HIF-1a prolyl hydroxylation levels in HeLa cells following ABHD11 
depletion, DMOG treatment or VHL inhibition. Control or ABHD11 deficient HeLa cells were 
generated as described. Hela cells were treated with indicated concentration of DMOG for 24 
hr or the VHL inhibitor VH298 for 2 hours. Total HIF-1a and prolyl hydroxylated HIF-1a (OH-
HIF-1a) were measured by immunoblot. (h, i) In vitro prolyl hydroxylation of HIF-1a. 
Recombinant HIF-1a, encoding the C-terminal ODD region (aa 530 – 652), was incubated with 
cell extracts from control, ABHD11 deficient or LIAS deficient cells for 15 min at 37°C. Total 
HIF-1aODD and prolyl hydroxylated HIF-1aODD (OH-HIF-1a) were measured by immunoblot (h) 
and quantified using ImageJ (i). n=4 (representative image shown), mean ± SEM, two-tailled t 
test. (j) 5hmC levels are reduced in ABHD11 depleted cells. Genomic DNA was extracted from 
Hela control or mixed KO populations of ABHD11, LIAS or VHL, and 5hmC levels measured by 
immunoblot, compared to total DNA content measured by methylene blue stain (Figure 1j). 
(k) Effect of ABHD11 loss on histone methylation marks. Control, ABHD11, OGDH or LIAS 
deficient HeLa cells were generated as previously described. Wildtype Hela cells were also 
treated with DM2-OG (6mM 24hr) as indicated. H3K4me3, H3K9me3 and total H3 levels were 
measured by immunoblot. Short and long lipoate immunoblot exposures are shown. 
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Supplementary Figure 2. ABHD11 is a member of the ab hydrolase domain containing 
family 
 
(a) Hierarchical clustering of canonical protein sequences of ABHD family members using 
Clustal Omega. ABHD11 and ABHD10 contain mitochondrial targeting sequences (MTS). (b) 
Multiple sequence alignment of the canonical transcript variant of ABHD family members 
using Cluistal Omega, showing the regions aligning to ABHD11 active site residues serine 
141 and histidine 296. Residues are coloured by amino acid properties (red: 
small/hydrophobic; blue: acidic; magenta: basic; green: hydroxyl/sulfhydryl/amine, or 
glycine).   
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Supplementary Figure 3. ABHD11 is a mitochondrial matrix hydrolase. 
 
 
(a, b) Confocal immunofluorescence microscopy of Hela cells stably expressing ABHD11-GFP, 
ABHD11 S141-GFP or ABHD11 H296A-GFP (a). MitoTracker Deep Red was used to visualise 
mitochondria. Pearson correlation coefficient was used to quantify ABHD11 colocalisation 
with mitochondria (b). Scale=10µm. *p=0.017, two-tailed Mann Whitney U test.  ns=not 
significant (S141A vs wt: p=0.90; H296A vs wt: p=0.32). 
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Supplementary Figure 4. Affinity purification of ABHD11-FLAG. 
 
(a) Purification of wildtype or S141A mutant ABHD11 from human cells. HEK293T cells were 
transfected with wildtype of S141A ABHD11-FLAG. Cells were lysed after 48 hr (left panel) 
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and ABHD11 affinity purified using anti-FLAG affinity beads and FLAG peptide elution (middle 
(immunoblot) and right panel (Coomassie staining)). The pre-cleaved (pABHD11) and 
mitochondrial cleaved (mABHD11) forms are indicated. (b) Mass spectrometry (MS) sequence 
analysis of affinity purified ABHD11-FLAG expressing HEK293T cells. Affinity purified ABHD11 
was subjected to SDS-PAGE and analysed by MS using three different peptide digests (Trypsin, 
AspN or GluC). Complete peptide coverage was observed aside from the first 21 residues 
encoding the mitochondrial targeting sequence and TOM20 recognition motif.  (c, d) Size 
exclusion chromatography of ABHD11-FLAG. Affinity purified ABHD11-FLAG was subjected to 
gel filtration using a Superdex 75 10/300 GL column. Two peaks were visualised, potentially 
corresponding to monomeric and dimeric forms. ABHD11-FLAG was only visualised in the 
second peak elution (d). 
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Supplementary Figure 5. ABHD11 loss does not alter PDHc activity. 
 
 
(a) Lipoylation of immunoprecipitated DLST. Control, ABHD11 mixed KO or LIAS mixed KO cells 
were lysed in 1% IGEPAL CA-630 and DLST immunoprecipitated. DLST and lipoylated DLST 
levels are shown. HC = heavy chain. (b) Lipoylation of immunoprecipitated DLAT. Control, 
ABHD11 mixed KO or LIAS mixed KO cells were lysed in 1% IGEPAL CA-630 and DLAT 
immunoprecipitated. DLAT and lipoylated DLAT levels are shown. 
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Supplementary Figure 6. ABHD11 loss does not alter PDHc activity. 
 
(a-h) Stable isotope tracing in HeLa cells compared to mixed CRISPR KO populations (sgRNA) 
of ABHD11, OGDH or pyruvate dehydrogenase E1 alpha subunit (PDHA1) incubated with [U-
13C6]-glucose. Isotopologues of pyruvate (b), and phosphoenolpyruvate (PEP) (c) confirm that 
PDHA1 loss impaired PDHc function, resulting in pyruvate and PEP accumulation. 
Isotopologues of 2-OG (d) and malate (e) confirm that ABHD11 and OGDH loss impairs the 
TCA cycle by decreased OGDHc activity, within increased 2-OG and decreased malate. Serine 
(f) and aspartate (g) increases following PDHA1 loss are consistent with decreased PDHc 
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function. ABHD11 and OGDH loss do not increase serine or aspartate pools (f, g). (h) Lactate 
levels are increased with PDHA1 loss but not with ABHD11 or OGDH depletion. Two 
biologically independent samples are shown; n=5 technical replicates per sample, mean ± SD. 
The m+0 to m+5 isotopologues are indicated.  
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Supplementary Figure 7. ABHD11 prevents the formation of lipoyl adducts on the OGDHc 
 
 
 
(a) Schematic of lipoic acid synthesis and conjugation pathway. Mitochondrial fatty acid 
synthesis provides the octanoylated (Oc) precursor for lipoic acid synthesis. MECR is upstream 
of octanoylated ACP, converting Trans-2-enoyl-ACP to acyl-ACP. LIPT2 catalyses the transfer 
of octanoate to GCSH. LIAS converts octanoate to lipoate. LIPT1 is thought to be the major 
lipoyl transferase allowing conjugation to conserved lysine residues in 2-oxoacid 
dehydrogenase subunits such as DLAT and DLST. (b) Depletion of lipoic acid synthesis and 
conjugation components in HeLa cells. Mixed HeLa KO populations of MECR, LIPT2, LIPT1, LIAS 
and ABHD11 were generated and immunoblotted for lipoylated proteins. b-actin served as a 
loading control.  
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Supplementary Figure 8. The effect of ABHD11 depletion or inhibition on cell growth and 
mitochondrial ROS. 
 
(a) ML226 treatment does not alter cell growth. HeLa cells were treated with 1µM ML226 or 
a DMSO control, and cell growth monitored over 4 days (n=3 biologically independent 
samples, mean ± SD). (b) LC-MS quantification of glutathione (GSH) isotopologues from [U-
13C5] glutamine treated control HeLa cells compared to mixed CRISPR KO populations 
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(sgRNA) of ABHD11 or OGDH (two biologically independent samples; n=5 technical 
replicates per sample, mean ± SD). (c, d) Mitochondrial ROS levels following OGDH, LIAS, 
PHD2 or ABHD11 depletion. HeLa Cas9 cells were transduced with sgRNA targeting OGDH, 
LIAS, PHD2 (c) or ABHD11 (d). After 10-13 days cells were stained with MitoSOX Red, and 
fluorescence measured by flow cytometry. Treatment with Antimycin A (10 µM, 30 min 37 
°C) was used as a positive control for mitochondrial ROS. Example of gating strategy is 
shown in Supplementary Figure 10b. (e) HRE-GFPODD reporter levels following treatment 
with Antimycin A (10µM) for 30 min at 37°C showed no change in GFP fluorescence 
compared to control cells treated with DMSO.  
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Supplementary Figure 9. ABHD11 prevents the formation of lipoyl adducts on the OGDHc 
 
(a) Effect of N-ethyl maleimide (NEM) treatment on protein lipoylation detected by 
immunoblot. Control or ABHD11 deficient HeLa cells were lysed in a HEPES buffer, and free 
thiols in HeLa cells were blocked with the addition of 10mM NEM (4°C, 1 hour). Immunoblot 
of lipoylated proteins confirmed efficient blocking of free thiols. (b) Representative 
chromatograms of DLST peptide encoding the lipoylated region from HeLa cells, 
demonstrating that the m/z separation of the differently modified DLST peptide 
(DK*TSVQVPSPA). (c) Overexpression of ABHD11 catalytic inactive mutants renders cells 
more susceptible to lipoyl adduct formation. HeLa cells expressing ABHD11-GFP, ABHD11 
S141A-GFP, ABHD11 H296A-GFP or a GFP only lentivirus (pSFFV-GFP) were treated with 4-
HNE at the concentrations indicated, and lipoylation levels measured using the anti-lipoate 
antibody. Loss of lipoylation represents lipoyl adduct formation.  
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Supplementary Figure 10. Flow cytometry gating 
 
 
 
(a, b) Example of gating strategy from control samples of Figure 1d (a) and Supplementary 
Figure 8d (b). Cells are gated on forward scatter (FSc) and side scatter (SSc) to exclude cell 
fragments; no other gating or exclusion of data was performed. The percentage of live cells 
included in the subsequent analysis is displayed.  
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Supplementary Figure 11. Uncropped original scans 
 
 
 
 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 
 
 
 
 24 
Supplementary Table 1 
Gene 
symbol Protein name 
Peptide count 
Control 
ABHD11-HA  
WT S141A H296A 
ABHD11 ABHD11  1 666 500 308 
HSPA9 Stress-70 protein 16 34 32 41 
HSPD1 60 kDa heat shock protein 12 33 18 37 
LRPPRC Leucine-rich PPR motif-containing protein 24 17 12 8 
NME4 Nucleoside diphosphate kinase 18 19 13 13 
ATP5A1 ATP synthase subunit alpha 8 12 7 5 
ATP5B ATP synthase subunit beta 9 13 7 5 
SSBP1 Single-stranded DNA-binding protein 7 14 6 3 
MRPS27 28S ribosomal protein S27 13 6 5 4 
TFAM Transcription factor A 8 4 4 5 
GCDH Glutaryl-CoA dehydrogenase 11 6 4 6 
MRPS34 28S ribosomal protein S34 7 5 8 2 
CPS1 Carbamoyl-phosphate synthase 1 8 2 10 
ACAD9 Acyl-CoA dehydrogenase family member 9 7 5 4 6 
SLC25A3 Phosphate carrier protein 5 5 2 5 
TUFM Elongation factor Tu 3 8 3 2 
PGAM5 Serine/threonine-protein phosphatase 
PGAM5, mitochondrial 
3 4 5 5 
SHMT2 Serine hydroxymethyltransferase 1 7 1 3 
SLC25A1 Tricarboxylate transport protein 5 2 2 4 
DLST Dihydrolipoyllysine-residue 
succinyltransferase  
1 4 2 2 
DLAT Dihydrolipoyllysine-residue acetyltransferase  1 3 3 1 
OGDH 2-oxoglutarate dehydrogenase 0 3 2 4 
 
Top mitochondrial proteins identified with immunoprecipitation-LC-MS using ABHD11-HA 
overexpressed in HeLa cells. The number of confidently (>90%) assigned unique peptides 
identified in each sample by Scaffold (Proteome Software, Inc) is displayed on the right, for 
each protein in each sample. The gene symbol and name of the top 23 proteins (out of 53), 
ordered by total peptide count, is displayed.   
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Supplementary Table 2 
Reagents and Antibodies  Source Identifier 
Antibodies 
Rabbit polyclonal anti-5hmC 
Dot blot: 1:10,000 
Active Motif Cat#39770; RRID: 
AB_10013602 
Lot 2158003 
Rabbit polyclonal anti-ABHD11 
Immunoblot: 1:2000 
Signalway Cat#34366 
Lot 4813 
Mouse monoclonal anti-β actin 
Immunoblot: 1:20,000 
Sigma Cat#A2228; RRID: 
AB_476697 
Lot 112M4762V 
Mouse monoclonal anti-Cytochrome C 
Immunoblot: 1:5000 
Abcam Cat#ab110325; 
RRID: AB_10864775 
Clone 37BA11 
Rabbit polyclonal anti-DLD 
Immunoblot: 1:2000 
GeneTex  Cat#GTX101245; 
RRID: AB_1240715 
Lot 39506 
Mouse monoclonal anti-DLAT 
Immunoblot: 1:2000 
Cell Signalling Cat#12362S; RRID: 
AB_2797893 
Clone 4A4-B6-C10 
Lot 1 
Mouse monoclonal anti-DLST (used for IP) Abcam Cat#ab110306; 
RRID: AB_10862702 
Clone 9F4BD5 
Lot 3278422-1 
Rabbit monoclonal anti-DLST (used for immunoblot) 
Immunoblot: 1:2000 
Cell Signalling Cat#11954; RRID: 
AB_2732907 
Clone D22B1 
Mouse monoclonal anti-GFP 
Immunoblot: 1:2000 
Roche Cat#11814460001; 
RRID: AB_390913 
Clones 7.1 & 13.1 
Rabbit monoclonal anti-H3 
Immunoblot: 1:2000 
Cell Signalling Cat#4499; RRID: 
AB_10544537 
Clone D1H2 
Rabbit monoclonal anti-H3K4me3 
Immunoblot: 1:1000 
Cell Signalling Cat#9751; RRID: 
AB_2616028 
Clone C42D8 
Rabbit monoclonal anti-H3K9me3 
Immunoblot: 1:1000 
Cell Signalling Cat# 13969; RRID: 
AB_2798355 
Clone D4W1U 
Rat monoclonal anti-HA 
Immunoblot: 1:2000 
 
Roche Cat#11867423001; 
RRID: AB_390918 
Clone 3D10 
Mouse monoclonal anti-HIF-1⍺	
Immunoblot: 1:1000 
BD Biosciences Cat#610959; RRID: 
AB_398272 
Lot 9049717 
Rabbit monoclonal anti-Hydroxy-HIF-1⍺	
Immunoblot: 1:1000 
Cell Signalling Cat#3434; RRID: 
RRID:AB_2116958 
Clone D43B5 
Lot 6 
 26 
Rabbit polyclonal anti-Lipoic acid 
Immunoblot: 1:2000 
Calbiochem Cat#437695; RRID: 
AB_212120 
Lot 3308897 
Rabbit polyclonal anti-MECR 
Immunoblot: 1:1000 
Proteintech Cat#51027-2-AP; 
RRID: AB_615013 
Lot 1537 
Mouse monoclonal anti-MFN2 
Immunoblot: 1:1000 
Abcam Cat#ab56889; RRID: 
AB_2142629 
Clone 6A8 
Mouse monoclonal anti-NDUFB8 
Immunoblot: 1:2500 
Abcam Cat#ab110242; 
RRID: AB_10859122 
Clone 20E9DH10C12 
Rabbit polyclonal anti-OGDH 
Immunoblot: 1:1000 
Immunofluorescence microscopy: 1:100 
Atlas Antibodies Cat#HPA020347; 
RRID: AB_1854773 
Lot A74004 
Rabbit polyclonal anti-PHD2 (EGLN1) 
Immunoblot: 1:2000 
Novus Cat#NB100-137; 
RRID: AB_10003054 
Lot A3 
Alexa-Fluor 647 Goat Anti-Rabbit IgG 
Microscopy secondary: 1:1000 
Thermo Cat#A21245; 
RRID:AB_2535813 
Lot 1558736 
Peroxidase-AffiniPure Goat Anti-Mouse IgG 
Immunoblot secondary: 1:20,000 
Jackson Cat#115-035-146; 
RRID:AB_2307392 
Peroxidase-AffiniPure Goat Anti-Rabbit IgG 
Immunoblot secondary: 1:20,000 
Jackson Cat#111-035-045; 
RRID: AB_2337938 
Peroxidase-AffiniPure Goat Anti-Rat IgG 
Immunoblot secondary: 1:20,000 
Jackson Cat#112-035-167; 
RRID: AB_2338139 
Reagents 
Antimycin A Alfa Aesar Cat#J63522; CAS: 
1397-94-0s 
Dimethyloxalylglycine Cayman Chemical Cat#71210; CAS: 
89464-63-1 
FCCP Cayman Chemical Cat#15218; CAS: 
370-86-5 
Sodium oxamate Sigma Cat# O2751; CAS: 
565-73-1   
GSK-2837808A Tocris CAS: 1445879-21-9 
ML226 Cayman Chemical Cat#25681; CAS: 
2055172-43-3 
Oligomycin A Cayman Chemical Cat#11342; CAS: 
579-13-5 
Rotenone Sigma Cat#R8875; CAS: 83-
79-4 
VH298 A gift from Alessio 
Ciulli 
 
MitoSOX Red ThermoFisher 
Scientific 
Cat#M36008 
3xFLAG Peptide Sigma Cat#F4799 
His-HIF-1⍺ODD (aa530-652) Burr et al, 2016  
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Supplementary Table 3 
 
CRISPR sgRNA oligonucleotide sequences 
ABHD11 sgRNA 1 TGCTGTAGATATCAGCCCAG 
ABHD11 sgRNA 2 AAGATCTTGGCCCAGCAGAC 
ABHD11 sgRNA 3 GCTGTGGCCAACGACGACGC 
ABHD11 sgRNA 4 GCAGAAGGTCCTGCAGGTCC 
LIAS sgRNA 1 TTAGGTTAAGACTACCTCCA 
LIPT1 sgRNA 1 ATGCCTACCAATTACAACAG 
LIPT1 sgRNA 2 GTAGCCTGCACATCCAGCTG 
LIPT2 sgRNA 1 CAGGCGCACCAACCGAACGG 
LIPT2 sgRNA 2 TATACGGCCGGGCTGCGCGG 
MECR sgRNA 1 GCAGGGATTGACACCCAGGG 
MECR sgRNA 2 GAAGTCCATCAACATCCTGT 
OGDH sgRNA 1 CTGCTCTTACCTCCAGCCGA 
OGDH sgRNA 2 TTCCTGTCCCCCGATGAAAG 
PDHA1 sgRNA 1 GATGCAGACTGTACGCCGAA 
PDHA1 sgRNA 2 AGGATGGGCTCAAATACTAC 
PHD2 sgRNA 1 ATGCCGTGCTTGTTCATGCA 
VHL sgRNA 1 GTGCCATCTCTCAATGTTGA 
 
Custom screen primers (TKO) 
TKO Inner PCR forward AATGATACGGCGACCACCGAGATCTACA 
CTCTCTTGTGGAAAGGACGAGGTACCG 
TKO custom sequencing primer ACACTCTCTTGTGGAAAGGACGAGGTACCG 
 
NEBuilder HiFi PCR primers to clone ABHD11 into pHRSIN lentiviral vector 
Forward CAGTCCTCCGACAGACTGAGTCGCCCGGGGG 
GGATCCGCCACCATGcgagccggccaacagcttgcaa 
Reverse CTTGCATGCCTGCAGGTCGACTCTAGAGTCGC 
GGCCGCttagaccaggaagcctcggatggcagc 
 
NEBuilder HiFi PCR primer to clone ABHD11 with C-terminal GFP tag into pHRSIN lentiviral vector 
Reverse (for ABHD11) CTTGCTCACgaccaggaagcctcggatggc 
Forward (GFP) gcttcctggtcGTGAGCAAGGGCGAGGAGCTG 
Reverse (GFP) GTCGACTCTAGAGTCGCGGCCGCttaCTTGTA 
CAGCTCGTCCATGCCGAG 
 
NEBuilder HiFi PCR primer to clone ABHD11 with C-terminal HA tag 
Reverse GTCGACTCTAGAGTCGCGGCCGCttaCT 
TGTACAGCTCGTCCATGCCGAG 
 
 
NEBuilder HiFi PCR primers to create silent mutations in ABHD11 sgRNA site 2 (mutations 
capitalised) 
Forward caaAatACtCgcAcaAcaAacaggccgtagggtg 
Reverse gtTtgTtgTgcGaGTatTttggcgatggagttgaagttag 
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NEBuilder HiFi PCR primers to create S141A active site mutation in ABHD11 
Forward cacGCGatgggaggaaagacag 
Reverse catCGCgtggccaacgacgac 
 
NEBuilder HiFi PCR primers to create H296A active site mutation in ABHD11 
Forward ccgaacgctggcGCc 
Reverse cagcgtggatccagGCg 
 
Gibson Assembly PCR primers to clone ABHD11 into pCEFL 3xFLAG mCherry vector 
Forward GGAATTGGCGAAGCTTGGTACCGAGCTCGG 
ATCCGCCACCATGcgagccggccaacagcttgcaa 
Reverse CCGTCATGGTCTTTGTAGTCAGCCCGCTCG 
AGCGGCCGCCCgaccaggaagcctcggatggcagc 
 
QPCR primers 
GAPDH Forward  ATGGGGAAGGTGAAGGTCG 
GAPDH Reverse CTCCACGACGTACTCAGCG 
CAIX Forward GCCGCCTTTCTGGAGGA 
CAIX Reverse TCTTCCAAGCGAGACAGCAA 
VEGF Forward TACCTCCACCATGCCAAGTG 
VEGF Reverse ATGATTCTGCCCTCCTCCTTC 
List of sgRNA sequences used, and PCR primers used for genome-wide screen amplification 
and sequencing, and cloning of ABHD11 expression vectors. 
 
 
